secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quince Therapeutics, Inc. (QNCX)
CIK:        0001662774
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001193125-22-307303
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Quince Therapeutics receives Nasdaq bid price deficiency notice; 180-day cure period.
--------------------------------------------------------------------------------

- Notice on Dec 13, 2022: closing bid price below $1.00 for 30 consecutive days.
- Initial compliance period until June 12, 2023 to regain bid price ≥$1.00 for 10 days.
- If not compliant by June 12, may transfer to Nasdaq Capital Market for second 180-day period.
- Failure to cure could result in delisting from Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1662774/000119312522307303/0001193125-22-307303-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1662774/000119312522307303/d433742d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-307303

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer